Tele-Intensive Care Unit (ICU) Market - Global Outlook and Forecast 2022-2027

Tele-Intensive Care Unit (ICU) Market - Global Outlook and Forecast 2022-2027

The global Tele-Intensive Care Unit (ICU) market is expected to grow with a CAGR of 19.69% from 2022 to 2027

MARKET INSIGHTS

In recent years, the number of patients requiring ICU care has increased without a corresponding growth in the availability of intensivists. Critical care is in high demand due to a dearth of intensivists, a smaller number of ICUs, and the expansion of the pandemic. Through real-time, remote consulting drastically lowers ICU mortality. Tele-ICU makes remote critical care and full-time bedside care accessible as the demand for critical care and full-time bedside care grows.

KEY HIGHLIGHTS OF THE INDUSTRY

The shortage of critical care specialists is burdening hospitals globally. Many small rural hospitals often struggle to hire critical care specialists and retain critical care centers due to a lack of reporting on holidays and weekends.

The burden of serious illness in low-income countries is high and can increase with increasing urbanization, epidemics, and less access to hospitals. Therefore, data on intensive care capabilities that consider access to both physical resources and healthcare professionals are essential to planning a healthcare system but are generally lacking or difficult to find.

The number of ICU beds in low & middle-income countries (LMIC) is estimated to be less than 3 ICU beds per 100,000 population. In contrast, high-income countries (HIC) are estimated to be more than 30 intensive care beds per 100,000 inhabitants. Tele-ICU shows potential as a clinically and economically viable approach to expanding healthcare infrastructure in developing countries.

COVID-19 PANDEMIC IMPACT ANALYSIS

  • The global COVID-19 outbreak has underlined the crucial role that modern technology can play in critical care in the twenty-first century.
  • The COVID‐19 pandemic has exhausted health care systems, emphasizing ICU bed capacity burdens, specifically in outbreak hotspots. ICU beds are necessary to treat the sickest COVID‐19 patients and are always the subject of bed capacity concerns.
  • Due to the adoption of the Tele-Intensive Care Unit, clinicians can now treat critically ill COVID-19 patients without exposing themselves or others around them to the highly contagious disease.
  • It has also provided smaller, regional hospitals with unprecedented access to high-quality intensive care management from critically qualified specialists. The COVID-19 pandemic has also brought attention to the acute shortage of critical care physicians, which was already a concern before the epidemic.
  • The situation was disastrous in some metropolitan hospitals and worsened in many regional hospitals. These small hospitals lack the expertise needed to treat complex and critically ill patients and usually transfer such patients to more extensive facilities with the right equipment and personnel
  • Amidst the COVID‐19 outbreak, intensive care unit telemedicine is essential to facilitate high‐quality patient care, particularly in rural parts of the US.
  • Tele Intensive Care Unit networks in rural areas are often set up in a hub-and-spoke model, and central hub hospitals host many of the resources that are virtually deployed to multiple-spoke hospitals requiring critical care services.
MARKET DRIVING FACTORS

Tele-ICU Partnership Yields Clinical and Administrative Benefits

a) The tele-ICU has proven to be effective in generating significant clinical and efficiency gains in hospital Intensive Care Units across the globe, starting with saving lives, reducing the length of stay (LOS), lowering infection rates, and ventilator time.

b) The reduced mortality rate is the essential benefit of a successful tele-ICU relationship. Actual performance is often compared to APACHE (Acute Physiology and Chronic Health Evaluation).

c) Tele- Intensive Care Unit teams can collaborate with clinicians and respiratory therapists at the bedside to extubate patients more quickly and cut down on ventilation days. Based on prior findings, better ventilator management in a 30-bed ICU at a hospital that earns $2,700 per vented day might save 794 ventilated days each year, resulting in a cost savings of over $2.1 million.

d) Tele- Intensive Care Unit solutions are becoming more popular to improve clinical outcomes while addressing the shortage of intensivists and lowering costs. A robust technology platform, a way to provide qualified and credentialed intensivist-led teams around the clock, process integration and modification, close collaboration, launch, and ongoing client relationship management are all required for a successful partnership.

High Growth Potential for Tele-ICU In LMICS

a) Acute care for critically ill patients is a global concern, regardless of the capabilities of the healthcare system. However, the high cost of trained medical staff, infrastructure, and consumables limit the development of intensive care units in low-income countries.

b) LMIC remains significant, mortality rates remain unacceptably high compared to HIC, and an estimated number of premature deaths exceeds 8 million. Given the prevalence of infectious diseases and the increased burden of non-communicable diseases such as cardiovascular disease, diabetes, and chronic obstructive pulmonary disease, LMIC's latest critical care program can help reduce this burden.

c) Highly skilled and well-qualified doctors and nurses are usually located in or near major cities, but remote areas often have limited access to critical care services. For example, in India, 80% of doctors work in urban areas, while 70% of the population live in remote areas suffering from a serious shortage of doctors and trained emergency workers.

d) The tele-Intensive Care Unit shows potential as a clinically and economically viable approach to expanding healthcare infrastructure in developing countries.

Growing Target Pool of Patients Requiring Tele-ICU Services

a) 90% of persons over 65 are thought to have one or more chronic illnesses that necessitate special treatment and care, setting them distinct from the rest of the population.

b) Non-communicable disease (NCD), a chronic disease, usually results from a combination of long-lasting, genetic, physiological, environmental, and behavioral factors.

c) According to a Global Disease Burden 2017 survey, an estimated 22.8 million cases of sepsis occurred in Asia in 2017, accounting for 47% of all cases worldwide.

d) According to the National Safety Council, the top 3 preventable related injury deaths are poisoning, motor vehicle, and falls, accounting for over 86% of all preventable deaths.

SEGMENTATION ANALYSIS

a) The centralized tele-ICU market reported a major share of around 51.65% in 2021 due to wider acceptance across the globe. The Centralized Tele-ICU is a hub-and-spoke model, where critical care services originate from the hub and services are delivered by the spoke facilities. A hub (or center) is an established site with staff, including emergency physicians, nurses, and clinical and technical staff. The established hub is connected to one or more medical facilities and/or several ICUs. Centralized tele Intensive Care Unit can:
  • Continuously collect and analyze data
  • Allows data to be researched over time trends, allowing providers to draw conclusions and make meaningful contributions to managing the health of critical patient populations.
  • The centralized Tele Intensive Care Unit is ideally suited for vertical growth, including more critical care programs, by extending the same service line with more critical care staff.
Market Segmentation by Model
  • Centralized Tele-ICU
  • Decentralized Tele-ICU
  • Hybrid Tele-ICU
b) The hardware segment reported a major share of around 68.76% in 2021. Hardware segments include computer systems, communication lines, high-resolution cameras, video display boards, physiological monitors, medical records, and more. The Tele- Intensive Care Unit system includes hardware that collects and compiles patient data and sends it remotely. Patient data includes physiological conditions (such as EKG and blood oxygen saturation), treatment (such as specific drug infusion rates and ventilator settings), and medical records.

Market Segmentation by Component
  • Hardware
  • Service
  • Software
c) The adult Patients segment reported a major share of around 80.73% among all Patient groups in 2021. The adult patient segment is witnessing a high share because non-communicable disease (NCDs) is one of the leading causes of death globally, accounting for about 41% of all deaths globally. Thus, increasing chronic disease in the adult population has surged the share of adult patients. NCDs impact people of all ages, from all walks of life, areas, and countries. Although these diseases are frequently associated with older age groups, research suggests that more than 15 million of all NCD-related fatalities occur between the ages of 30 and 69.

Market Segmentation by Patient Group
  • Adult Patients
  • Neonatal & Pediatric Patients
d) Among all Hospital types, the system Affiliated Hospitals segment reported a major share of around 69.57% in 2021. The system Affiliated Hospital's segment is the witness of high share because the network's hospitals collaborate to deliver various services to single or numerous communities. Participating in a hospital network is cost-effective mainly because it improves efficiency, eliminates service redundancy, and ensures that all patients, whether in small towns or large cities, receive high-quality care. There are numerous advantages.

Market Segmentation by Hospital Type
  • System Affiliated Hospitals
  • Independent Hospitals
GEOGRAPHY ANALYSIS

North America reported a significant share of around 40.84% in 2021, because the US has the world's highest number of ICU beds per capita. Over 5 million patients are admitted to the Intensive Care Unit in the US annually for intensive care or invasive monitoring. Approximately 2,100 rural hospitals that provide rural Americans with access to community care can be difficult to provide critical care during a surge in events. Tele-Intensive Care Unit can be a mechanism by which local hospitals can provide critical care to local Americans.

Market Segmentation by Geography
  • North America
o US

o Canada
  • Europe
o Germany

o France

o UK

o Italy

o Spain
  • APAC
o China

o Japan

o India

o South Korea

o Australia
  • Latin America
o Brazil

o Mexico

o Argentina
  • Middle East & Africa
o Turkey

o Saudi Arabia

o South Africa

o UAE

VENDOR ANALYSIS

The market is consolidated as prominent players cover the market's larger share. For instance, GE Healthcare, Koninklijke Philips, Teladoc, and Hicuity Health have vast product and service offerings required by the Tele-ICU system. These companies are offering robust tele-ICU systems such as the Philips eICU program, a transformational critical care tele-ICU program that combines A/V technology, predictive analytics, data visualization, and advanced reporting capabilities, delivered by Philips experts with more than 15 years of proven success.

Other challenging players such as Apollo telehealth, SOC Telemed, intercept Telemed, and Eagle Telemedicine also has a significant share in the regional market and focus on continuous expansion. This is further intensifying the competition in the global market.

Key Vendors
  • Apollo TeleHealth
  • Eagle Telemedicine
  • GE Healthcare
  • Hicuity Health
  • Intercept Telemed
  • Koninklijke Philips
  • SOC Telemed
  • Teladoc health.
Other Prominent Vendors
  • Avel eCare
  • Ceiba Health
  • CLEW
  • Cloudphysician
  • CritiNext
  • iMDsoft
  • RemoteICU
  • Sri Laxmi Kravia Techlabs
  • VeeOne Health
  • eNext ICU
  • Inova
  • T-ICU
KEY QUESTIONS ANSWERED:

1. How big is the global Tele-ICU market?

2. What is the growth rate of the global Tele-ICU market?

3. What are the growth factors in the Tele-ICU market?

4. Who are the key players in the global Tele-ICU market?


1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
7.2 TELE-ICU: FUTURE OF INTENSIVE CARE
7.2.1 CHANGING PARADIGM OF INTENSIVE CARE UNITS (ICUS)
7.3 COVID-19 & TELE-ICU
7.3.1 PRESSING DEMAND FOR ADVANCED HEALTHCARE TECHNOLOGIES
7.3.2 LEAPFROG IMPACT OF TELE-ICU SOLUTIONS
8 PREMIUM INSIGHTS
8.1 MARKET OVERVIEW
8.1.1 GLOBAL TELE-ICU MARKET SCENARIO
8.2 GLOBAL TELE-ICU MARKET SEGMENTATION
8.2.1 INSIGHTS BY MODEL SEGMENTATION
8.2.2 INSIGHTS BY COMPONENT SEGMENTATION
8.2.3 INSIGHTS BY PATIENT GROUP SEGMENTATION
8.2.4 INSIGHTS BY HOSPITAL TYPE SEGMENTATION
8.2.5 INSIGHTS BY GEOGRAPHY SEGMENTATION
9 MARKET OPPORTUNITIES & TRENDS
9.1 HIGH GROWTH POTENTIAL FOR TELE-ICU IN LMICS
9.2 TECHNOLOGICAL ADVANCES IN TELE-ICUS
9.3 CLINICAL & ADMINISTRATIVE BENEFITS OF TELE-ICU PARTNERSHIPS
10 MARKET GROWTH ENABLERS
10.1 COVID-19 & SURGE IN ADOPTION OF TELE-ICU SOLUTIONS WORLDWIDE
10.2 INCREASE IN ICU ADMISSION RATES & HIGH ADOPTION OF TELE-ICUS
10.3 SHORTAGE OF CRITICAL CARE STAFF & RISE IN DEMAND FOR TELE-ICUS
10.4 GROWING TARGET POOL OF PATIENTS REQUIRING TELE-ICU SERVICES
11 MARKET RESTRAINTS
11.1 IMPLEMENTATION BARRIERS FOR TELE-ICUS
11.2 HIGH INVESTMENT IN ESTABLISHING TELE-ICU INFRASTRUCTURE
11.3 COMPLEX IDENTITY & ACCESS MANAGEMENT LIMITATIONS OF TELE-ICUS
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 INSIGHTS BY GEOGRAPHY
12.2.2 INSIGHTS BY MODEL
12.2.3 INSIGHTS BY COMPONENT
12.2.4 INSIGHTS BY PATIENT GROUP
12.2.5 INSIGHTS BY HOSPITAL TYPE
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 MODEL
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 CENTRALIZED TELE-ICU
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 DECENTRALIZED TELE-ICU
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.5 HYBRID TELE-ICU
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
14 COMPONENT
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 TELE-ICU HARDWARE
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 TELE-ICU SERVICES
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 TELE-ICU SOFTWARE
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
15 PATIENT GROUP
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 ADULT PATIENTS
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 NEONATAL & PEDIATRIC PATIENTS
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
16 HOSPITAL TYPE
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 SYSTEM AFFILIATED HOSPITALS
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 MARKET BY GEOGRAPHY
16.4 INDEPENDENT HOSPITALS
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.4.3 MARKET BY GEOGRAPHY
17 GEOGRAPHY
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 GEOGRAPHIC OVERVIEW
18 NORTH AMERICA
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.2.1 NORTH AMERICA: MODEL SEGMENTATION
18.2.2 NORTH AMERICA: COMPONENT SEGMENTATION
18.2.3 NORTH AMERICA: PATIENT GROUP SEGMENTATION
18.2.4 NORTH AMERICA: HOSPITAL TYPE SEGMENTATION
18.3 KEY COUNTRIES
18.3.1 US: MARKET SIZE & FORECAST
18.3.2 CANADA: MARKET SIZE & FORECAST
19 EUROPE
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.2.1 EUROPE: MODEL SEGMENTATION
19.2.2 EUROPE: COMPONENT SEGMENTATION
19.2.3 EUROPE: PATIENT GROUP SEGMENTATION
19.2.4 EUROPE: HOSPITAL TYPE SEGMENTATION
19.3 KEY COUNTRIES
19.3.1 GERMANY: MARKET SIZE & FORECAST
19.3.2 FRANCE: MARKET SIZE & FORECAST
19.3.3 UK: MARKET SIZE & FORECAST
19.3.4 ITALY: MARKET SIZE & FORECAST
19.3.5 SPAIN: MARKET SIZE & FORECAST
20 APAC
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.2.1 APAC: MODEL SEGMENTATION
20.2.2 APAC: COMPONENT SEGMENTATION
20.2.3 APAC: PATIENT GROUP SEGMENTATION
20.2.4 APAC: HOSPITAL TYPE SEGMENTATION
20.3 KEY COUNTRIES
20.3.1 JAPAN: MARKET SIZE & FORECAST
20.3.2 CHINA: MARKET SIZE & FORECAST
20.3.3 INDIA: MARKET SIZE & FORECAST
20.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
20.3.5 AUSTRALIA: MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.2.1 LATIN AMERICA: MODEL SEGMENTATION
21.2.2 LATIN AMERICA: COMPONENT SEGMENTATION
21.2.3 LATIN AMERICA: PATIENT GROUP SEGMENTATION
21.2.4 LATIN AMERICA: HOSPITAL TYPE SEGMENTATION
21.3 KEY COUNTRIES
21.3.1 BRAZIL: MARKET SIZE & FORECAST
21.3.2 MEXICO: MARKET SIZE & FORECAST
21.3.3 ARGENTINA: MARKET SIZE & FORECAST
22 MIDDLE EAST & AFRICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.2.1 MIDDLE EAST & AFRICA: MODEL SEGMENTATION
22.2.2 MIDDLE EAST & AFRICA: COMPONENT SEGMENTATION
22.2.3 MIDDLE EAST & AFRICA: PATIENT GROUP SEGMENTATION
22.2.4 MIDDLE EAST & AFRICA: HOSPITAL TYPE SEGMENTATION
22.3 KEY COUNTRIES
22.3.1 TURKEY: MARKET SIZE & FORECAST
22.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
22.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST
22.3.4 UAE: MARKET SIZE & FORECAST
23 COMPETITIVE LANDSCAPE
23.1 COMPETITION OVERVIEW
23.2 MARKET SHARE ANALYSIS
24 KEY COMPANY PROFILES
24.1 APOLLO TELEHEALTH
24.1.1 BUSINESS OVERVIEW
24.1.2 APOLLO TELEHEALTH IN GLOBAL TELE-ICU MARKET
24.1.3 SERVICE OFFERINGS
24.1.4 KEY STRATEGIES
24.1.5 KEY STRENGTHS
24.1.6 KEY OPPORTUNITIES
24.2 EAGLE TELEMEDICINE
24.2.1 BUSINESS OVERVIEW
24.2.2 EAGLE TELEMEDICINE IN GLOBAL TELE-ICU MARKET
24.2.3 SERVICE OFFERINGS
24.2.4 KEY STRATEGIES
24.2.5 KEY STRENGTHS
24.2.6 KEY OPPORTUNITIES
24.3 GE HEALTHCARE
24.3.1 BUSINESS OVERVIEW
24.3.2 GE HEALTHCARE IN GLOBAL TELE-ICU MARKET
24.3.3 SERVICE OFFERINGS
24.3.4 KEY STRATEGIES
24.3.5 KEY STRENGTHS
24.3.6 KEY OPPORTUNITIES
24.4 HICUITY HEALTH
24.4.1 BUSINESS OVERVIEW
24.4.2 HICUITY HEALTH IN GLOBAL TELE-ICU MARKET
24.4.3 SERVICE OFFERINGS
24.4.4 KEY STRATEGIES
24.4.5 KEY STRENGTHS
24.4.6 KEY OPPORTUNITIES
24.5 INTERCEPT TELEMED
24.5.1 BUSINESS OVERVIEW
24.5.2 INTERCEPT TELEMED IN GLOBAL TELE-ICU MARKET
24.5.3 SERVICE OFFERINGS
24.5.4 KEY STRATEGIES
24.5.5 KEY STRENGTHS
24.5.6 KEY OPPORTUNITIES
24.6 KONINKLIJKE PHILIPS
24.6.1 BUSINESS OVERVIEW
24.6.2 PHILIPS IS IN GLOBAL TELE-ICU MARKET
24.6.3 SERVICE OFFERINGS
24.6.4 KEY STRATEGIES
24.6.5 KEY STRENGTHS
24.6.6 KEY OPPORTUNITIES
24.7 SOC TELEMED
24.7.1 BUSINESS OVERVIEW
24.7.2 SOC TELEMED IN GLOBAL TELE-ICU MARKET
24.7.3 SERVICE OFFERINGS
24.7.4 KEY STRATEGIES
24.7.5 KEY STRENGTHS
24.7.6 KEY OPPORTUNITIES
24.8 TELADOC HEALTH
24.8.1 BUSINESS OVERVIEW
24.8.2 TELADOC HEALTH IN GLOBAL TELE-ICU MARKET
24.8.3 SERVICE OFFERINGS
24.8.4 KEY STRATEGIES
24.8.5 KEY STRENGTHS
24.8.6 KEY OPPORTUNITIES
25 OTHER PROMINENT VENDORS
25.1 AVEL ECARE
25.1.1 BUSINESS OVERVIEW
25.1.2 SERVICE OFFERINGS
25.1.3 KEY STRENGTHS
25.1.4 KEY OPPORTUNITIES
25.2 CEIBA HEALTH
25.2.1 BUSINESS OVERVIEW
25.2.2 SERVICE OFFERINGS
25.2.3 KEY STRENGTHS
25.2.4 KEY OPPORTUNITIES
25.3 CLEW
25.3.1 BUSINESS OVERVIEW
25.3.2 SERVICE OFFERINGS
25.3.3 KEY STRENGTHS
25.3.4 KEY OPPORTUNITIES
25.4 CLOUDPHYSICIAN
25.4.1 BUSINESS OVERVIEW
25.4.2 SERVICE OFFERINGS
25.4.3 KEY STRENGTHS
25.4.4 KEY OPPORTUNITIES
25.5 CRITINEXT
25.5.1 BUSINESS OVERVIEW
25.5.2 SERVICE OFFERINGS
25.5.3 KEY STRENGTHS
25.5.4 KEY OPPORTUNITIES
25.6 IMDSOFT
25.6.1 BUSINESS OVERVIEW
25.6.2 SERVICE OFFERINGS
25.6.3 KEY STRENGTHS
25.6.4 KEY OPPORTUNITIES
25.7 REMOTEICU
25.7.1 BUSINESS OVERVIEW
25.7.2 SERVICE OFFERINGS
25.7.3 KEY STRENGTHS
25.7.4 KEY OPPORTUNITIES
25.8 SRI LAXMI KRAVIA TECHLABS
25.8.1 BUSINESS OVERVIEW
25.8.2 SERVICE OFFERINGS
25.8.3 KEY STRENGTHS
25.8.4 KEY OPPORTUNITIES
25.9 VEEONE HEALTH
25.9.1 BUSINESS OVERVIEW
25.9.2 SERVICE OFFERINGS
25.9.3 KEY STRENGTHS
25.9.4 KEY OPPORTUNITIES
25.10 ENEXT ICU
25.10.1 BUSINESS OVERVIEW
25.10.2 SERVICE OFFERINGS
25.10.3 KEY STRENGTHS
25.10.4 KEY OPPORTUNITIES
25.11 INOVA
25.11.1 BUSINESS OVERVIEW
25.11.2 SERVICE OFFERINGS
25.11.3 KEY STRENGTHS
25.11.4 KEY OPPORTUNITIES
25.12 T-ICU
25.12.1 BUSINESS OVERVIEW
25.12.2 SERVICE OFFERINGS
25.12.3 KEY STRENGTHS
25.12.4 KEY OPPORTUNITIES
26 REPORT SUMMARY
26.1 KEY TAKEAWAYS
26.2 STRATEGIC RECOMMENDATIONS
27 QUANTITATIVE SUMMARY
27.1 MARKET BY MODEL
27.1.1 NORTH AMERICA: MODEL SEGMENTATION
27.1.2 EUROPE: MODEL SEGMENTATION
27.1.3 APAC: MODEL SEGMENTATION
27.1.4 LATIN AMERICA: MODEL SEGMENTATION
27.1.5 MIDDLE EAST & AFRICA: MODEL SEGMENTATION
27.2 MARKET BY COMPONENT
27.2.1 NORTH AMERICA: COMPONENT SEGMENTATION
27.2.2 EUROPE: COMPONENT SEGMENTATION
27.2.3 APAC: COMPONENT SEGMENTATION
27.2.4 LATIN AMERICA: COMPONENT SEGMENTATION
27.2.5 MIDDLE EAST & AFRICA: COMPONENT SEGMENTATION
27.3 MARKET BY PATIENT GROUP
27.3.1 NORTH AMERICA: PATIENT GROUP SEGMENTATION
27.3.2 EUROPE: PATIENT GROUP SEGMENTATION
27.3.3 APAC: PATIENT GROUP SEGMENTATION
27.3.4 LATIN AMERICA: PATIENT GROUP SEGMENTATION
27.3.5 MIDDLE EAST & AFRICA: PATIENT GROUP SEGMENTATION
27.4 MARKET BY HOSPITAL TYPE
27.4.1 NORTH AMERICA: HOSPITAL TYPE SEGMENTATION
27.4.2 EUROPE: HOSPITAL TYPE SEGMENTATION
27.4.3 APAC: HOSPITAL TYPE SEGMENTATION
27.4.4 LATIN AMERICA: HOSPITAL TYPE SEGMENTATION
27.4.5 MIDDLE EAST & AFRICA: HOSPITAL TYPE SEGMENTATION
27.5 MARKET BY GEOGRAPHY
27.5.1 CENTRALIZED TELE-ICU: GEOGRAPHY SEGMENTATION
27.5.2 DECENTRALIZED TELE-ICU: GEOGRAPHY SEGMENTATION
27.5.3 HYBRID TELE-ICU: GEOGRAPHY SEGMENTATION
27.5.4 TELE-ICU HARDWARE: GEOGRAPHY SEGMENTATION
27.5.5 TELE-ICU SERVICE: GEOGRAPHY SEGMENTATION
27.5.6 TELE-ICU SOFTWARE: GEOGRAPHY SEGMENTATION
27.5.7 ADULT PATIENTS: GEOGRAPHY SEGMENTATION
27.5.8 NEONATAL & PEDIATRIC PATIENTS: GEOGRAPHY SEGMENTATION
27.5.9 SYSTEM AFFILIATED HOSPITALS: GEOGRAPHY SEGMENTATION
27.5.10 INDEPENDENT HOSPITALS: GEOGRAPHY SEGMENTATION
28 APPENDIX
28.1 ABBREVIATIONS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings